DSCGX | NRGEX | DSCGX / NRGEX | |
Total Expense Ratio | 0.32 | 0.03 | 1,067% |
Annual Report Gross Expense Ratio | 0.32 | 0.69 | 46% |
Fund Existence | 13 years | 4 years | - |
Gain YTD | 5.291 | -3.342 | -158% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.72B | 8.69B | 20% |
Annual Yield % from dividends | 0.60 | 0.54 | 111% |
Returns for 1 year | 2.88 | -9.46 | -30% |
Returns for 3 years | 45.15 | 8.17 | 553% |
Returns for 5 years | 55.99 | N/A | - |
Returns for 10 years | 110.86 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNIX | 75.85 | 0.47 | +0.62% |
Janus Henderson Global Life Sciences I | |||
HRLVX | 22.93 | 0.13 | +0.57% |
Harbor Large Cap Value Admin | |||
HADUX | 79.12 | 0.41 | +0.52% |
Horizon Equity Premium Income Advisor | |||
VLLIX | 49.30 | 0.06 | +0.12% |
Value Line Larger Companies Focus Instl | |||
CLBEX | 38.90 | 0.04 | +0.10% |
American Funds American Balanced 529E |